Publications by authors named "Samuel R Perry"

Claim this Profile
A
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, Xinzhong Wang, Leslie K Wetzel

Cancer Cell· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGFR2-activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer cell models.
Samantha J Stehbens, Robert J Ju, Mark N Adams, Samuel R Perry, Nikolas K Haass

J Cell Sci· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody.
Vaheh Oganesyan, Li Peng, Jared S Bee, John Li, Samuel R Perry

J Biol Chem· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemically Diverse Helix-Constrained Peptides Using Selenocysteine Crosslinking.
Aline Dantas de Araujo, Samuel R Perry, David P Fairlie

Org Lett· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contiguous hydrophobic and charged surface patches in short helix-constrained peptides drive cell permeability.
Samuel R Perry, Timothy A Hill, Aline D de Araujo, Huy N Hoang, David P Fairlie

Org Biomol Chem· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downsizing Proto-oncogene cFos to Short Helix-Constrained Peptides That Bind Jun.
Daniel Baxter, Samuel R Perry, Timothy A Hill, W Mei Kok, Nathan R Zaccai

ACS Chem Biol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, Xinzhong Wang, Leslie K Wetzel

Cancer Cell· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist Discovery.
Samuel R Perry, Weijun Xu, Anna Wirija, Junxian Lim, Mei-Kwan Yau

J Chem Inf Model· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism.
Haoqiang Ying, Alec C Kimmelman, Costas A Lyssiotis, Sujun Hua, Gerald C Chu, Samuel R Perry

Cell· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases.
Zhihu Ding, Chang-Jiun Wu, Mariela Jaskelioff, Elena Ivanova, Maria Kost-Alimova, Samuel R Perry

Cell· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma.
Peter Olson, Gerald C Chu, Samuel R Perry, Olivier Nolan-Stevaux, Douglas Hanahan

Proc Natl Acad Sci U S A· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proinvasion metastasis drivers in early-stage melanoma are oncogenes.
Kenneth L Scott, Cristina Nogueira, Timothy P Heffernan, Remco van Doorn, Sabin Dhakal, Samuel R Perry

Cancer Cell· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network.
Haoqiang Ying, Kutlu G Elpek, Anant Vinjamoori, Stephanie M Zimmerman, Gerald C Chu, Samuel R Perry

Cancer Discov· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
Zhihu Ding, Chang-Jiun Wu, Gerald C Chu, Yonghong Xiao, Dennis Ho, Samuel R Perry

Nature· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomere dysfunction induces metabolic and mitochondrial compromise.
Ergün Sahin, Simona Colla, Marc Liesa, Javid Moslehi, Florian L Müller, Samuel R Perry

Nature· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas.
Hongwu Zheng, Haoqiang Ying, Ruprecht Wiedemeyer, Haiyan Yan, Steven N Quayle, Samuel R Perry

Cancer Cell· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
Hongwu Zheng, Haoqiang Ying, Haiyan Yan, Alec C Kimmelman, David J Hiller, Samuel R Perry

Nature· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis